Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

United Therapeutics (UTHR) Other Gross PP&E Adjustments (2016 - 2026)

United Therapeutics' Other Gross PP&E Adjustments history spans 16 years, with the latest figure at $2.3 billion for Q4 2025.

  • On a quarterly basis, Other Gross PP&E Adjustments rose 34.07% to $2.3 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $2.3 billion, a 34.07% increase, with the full-year FY2025 number at $2.3 billion, up 34.07% from a year prior.
  • Other Gross PP&E Adjustments hit $2.3 billion in Q4 2025 for United Therapeutics, up from $2.1 billion in the prior quarter.
  • Over the last five years, Other Gross PP&E Adjustments for UTHR hit a ceiling of $2.3 billion in Q4 2025 and a floor of $1.0 billion in Q1 2021.
  • Historically, Other Gross PP&E Adjustments has averaged $1.5 billion across 5 years, with a median of $1.4 billion in 2023.
  • Biggest five-year swings in Other Gross PP&E Adjustments: grew 7.92% in 2021 and later soared 34.07% in 2025.
  • Tracing UTHR's Other Gross PP&E Adjustments over 5 years: stood at $1.1 billion in 2021, then rose by 10.76% to $1.2 billion in 2022, then increased by 18.44% to $1.5 billion in 2023, then rose by 16.29% to $1.7 billion in 2024, then skyrocketed by 34.07% to $2.3 billion in 2025.
  • Business Quant data shows Other Gross PP&E Adjustments for UTHR at $2.3 billion in Q4 2025, $2.1 billion in Q3 2025, and $1.9 billion in Q2 2025.